Concerns among Calgarians over homelessness and transit safety are on the rise, while fears of violent crime are down, ...

Her scheme of enlisting foreign governments to stop U.S. mergers suffered a blow Tuesday when Europe’s high court ruled that regulators in Brussels exceeded their authority by blocking Illumina ...

In a case that had been closely watched across multiple industries, Illumina chose to divest Grail in the light of legal action from the European Commission and the US Federal Trade Commission.

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Europe’s top court dealt a blow to Brussels regulators on Tuesday after it agreed with US biotech ...

BRUSSELS, Sept 3 (Reuters) - U.S. gene sequencing company Illumina (ILMN.O), opens new tab on Tuesday won its court fight against the European Union's investigation ...

(RTTNews) - Illumina, Inc. (ILMN) Tuesday announced that the 432 million euros fine imposed by the European Commission over GRAIL deal is no longer be payable after favorable verdict by the ...

Though Illumina said goodbye to Grail this past summer—after butting heads for years with antitrust regulators and activist investors, while enduring heavy fines and orders to split—the ...

Illumina (NASDAQ: ILMN) a global leader in genomics, and LGC Biosearch Technologies™, a pioneer in agricultural genomics, today announced a strategic partnership to accelerate the adoption of ...

BENGALURU: Illumina, a global leader in DNA sequencing and array-based technologies, announced it will establish a Global CapabilityCenter in Bengaluru to expand its technology workforce in ...

Illumina, which founded Grail and spun it off in 2016 only to re-acquire it in 2021 for $7.1 billion, had fought against the European Commission's decision to wield a rarely-used power called ...

Canadians have prided themselves on embracing newcomers but polls show a growing number say Canada is admitting too many immigrants. That stance is filtering down to border and immigration ...

BRUSSELS (Reuters) -U.S. gene sequencing company Illumina on Tuesday won its court fight against the European Union's investigation of its $7.1 billion purchase of cancer diagnostic test maker Grail, ...